Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending May 6, 2023 (Week 18)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 15,100 32,600 471,899 557,340
New England 588 1,295 15,413 17,173
Connecticut - 253 1,156 3,648
Maine 58 81 954 1,168
Massachusetts 425 732 10,310 9,327
New Hampshire 35 93 872 1,052
Rhode Island 47 505 1,654 1,566
Vermont 23 37 467 412
Middle Atlantic 2,228 4,266 60,599 66,219
New Jersey 467 744 8,359 11,535
New York (excluding New York City) 856 1,532 13,869 13,027
New York City 15 1,456 19,287 22,259
Pennsylvania 890 1,234 19,084 19,398
East North Central 2,016 4,763 60,882 80,180
Illinois 89 1,518 13,985 24,707
Indiana 432 855 9,501 11,669
Michigan 302 962 10,639 14,647
Ohio 752 1,240 18,079 19,899
Wisconsin 441 559 8,678 9,258
West North Central 760 2,116 29,685 34,967
Iowa 62 333 4,591 5,233
Kansas 70 306 1,514 4,812
Minnesota 178 496 7,509 7,652
Missouri 401 730 10,535 10,862
Nebraska - 222 2,847 3,396
North Dakota - 91 1,011 1,283
South Dakota 49 124 1,678 1,729
South Atlantic 3,430 7,107 107,761 115,752
Delaware - 211 1,843 1,800
District of Columbia 94 188 2,875 2,783
Florida 1,900 2,781 38,015 34,794
Georgia - 1,525 20,799 24,578
Maryland U NC U U
North Carolina 12 1,404 16,486 22,771
South Carolina 669 884 11,471 12,932
Virginia 738 984 14,828 14,506
West Virginia 17 110 1,444 1,588
East South Central 1,107 2,505 33,812 37,416
Alabama 642 972 11,924 10,636
Kentucky 308 516 5,459 6,016
Mississippi - 526 5,776 7,199
Tennessee 157 1,085 10,653 13,565
West South Central 484 4,893 48,199 81,019
Arkansas 174 425 5,564 6,146
Louisiana 263 801 11,171 12,615
Oklahoma 47 422 3,510 6,959
Texas - 3,375 27,954 55,299
Mountain 1,460 2,494 35,835 39,629
Arizona 482 924 13,586 14,304
Colorado 454 793 9,386 8,485
Idaho 83 154 1,976 1,811
Montana 33 112 1,214 1,417
Nevada 176 361 2,591 5,501
New Mexico 18 262 2,739 3,647
Utah 189 246 3,774 3,903
Wyoming 25 54 569 561
Pacific 3,027 5,036 79,713 84,985
Alaska 44 121 1,523 1,860
California 2,311 4,101 65,690 66,704
Hawaii - 3 - 60
Oregon 313 356 5,300 5,608
Washington 359 635 7,200 10,753
U.S. Territories - 112 439 1,285
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 112 439 1,285
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 7 18 49
Total 15,101 32,685 472,356 558,674
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.